New Horizon Health Management
Management criteria checks 3/4
New Horizon Health's CEO is Yeqing Zhu, appointed in Jun 2018, has a tenure of 5.92 years. total yearly compensation is CN¥48.83M, comprised of 8.3% salary and 91.7% bonuses, including company stock and options. directly owns 3.36% of the company’s shares, worth HK$213.41M. The average tenure of the management team and the board of directors is 5.9 years and 3.3 years respectively.
Key information
Yeqing Zhu
Chief executive officer
CN¥48.8m
Total compensation
| CEO salary percentage | 8.3% |
| CEO tenure | 5.9yrs |
| CEO ownership | 3.4% |
| Management average tenure | 5.9yrs |
| Board average tenure | 3.3yrs |
Recent management updates
Recent updates
New Horizon Health Limited (HKG:6606) Stocks Shoot Up 29% But Its P/S Still Looks Reasonable
Mar 04
Should You Investigate New Horizon Health Limited (HKG:6606) At HK$18.38?
Jan 30Should You Think About Buying New Horizon Health Limited (HKG:6606) Now?
Sep 28New Horizon Health (HKG:6606) Is Posting Healthy Earnings, But It Is Not All Good News
Sep 28Benign Growth For New Horizon Health Limited (HKG:6606) Underpins Stock's 26% Plummet
Aug 02New Forecasts: Here's What Analysts Think The Future Holds For New Horizon Health Limited (HKG:6606)
Jul 14News Flash: Analysts Just Made A Substantial Upgrade To Their New Horizon Health Limited (HKG:6606) Forecasts
Mar 19Growth Investors: Industry Analysts Just Upgraded Their New Horizon Health Limited (HKG:6606) Revenue Forecasts By 26%
Jan 13News Flash: Analysts Just Made A Captivating Upgrade To Their New Horizon Health Limited (HKG:6606) Forecasts
Mar 23Need To Know: Analysts Are Much More Bullish On New Horizon Health Limited (HKG:6606) Revenues
Jan 19CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2023 | n/a | n/a | CN¥112m |
| Mar 31 2023 | n/a | n/a | CN¥16m |
| Dec 31 2022 | CN¥49m | CN¥4m | -CN¥79m |
| Sep 30 2022 | n/a | n/a | -CN¥169m |
| Jun 30 2022 | n/a | n/a | -CN¥259m |
| Mar 31 2022 | n/a | n/a | -CN¥2b |
| Dec 31 2021 | CN¥14m | CN¥3m | -CN¥3b |
Compensation vs Market: Yeqing's total compensation ($USD6.74M) is above average for companies of similar size in the Hong Kong market ($USD485.88K).
Compensation vs Earnings: Yeqing's compensation has been consistent with company performance over the past year.
CEO
Yeqing Zhu (51 yo)
5.9yrs
Tenure
CN¥48,829,000
Compensation
Mr. Yeqing Zhu serves as Executive Chairman at New Horizon Health Limited since June 20, 2022. He is the Chief Executive Officer of New Horizon Health Ltd. since June 7, 2018.Mr. Zhu is an Executive Direc...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, Executive Chairman & Co-founder | 5.9yrs | CN¥48.83m | 3.36% CN¥ 213.4m | |
| Executive Director & Chief Scientific Officer | 5.9yrs | CN¥11.04m | 8.14% CN¥ 516.4m | |
| CFO & Joint Company Secretary | 3.9yrs | no data | no data | |
| Chief Technology Officer | 8.5yrs | no data | no data | |
| Joint Company Secretary | 3.3yrs | no data | no data |
5.9yrs
Average Tenure
51yo
Average Age
Experienced Management: 6606's management team is seasoned and experienced (5.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, Executive Chairman & Co-founder | 5.9yrs | CN¥48.83m | 3.36% CN¥ 213.4m | |
| Executive Director & Chief Scientific Officer | 5.9yrs | CN¥11.04m | 8.14% CN¥ 516.4m | |
| Independent Non-Executive Director | less than a year | no data | no data | |
| Independent Non-executive Director | 3.3yrs | CN¥266.00k | no data | |
| Non-executive Director | 5.8yrs | no data | 5.14% CN¥ 325.9m | |
| Independent Non-executive Director | 3.3yrs | CN¥266.00k | no data | |
| Independent Non-Executive Director | less than a year | no data | no data | |
| Independent Non-executive Director | 3.3yrs | CN¥266.00k | no data |
3.3yrs
Average Tenure
53yo
Average Age
Experienced Board: 6606's board of directors are considered experienced (3.3 years average tenure).